BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal Period

Menopause Is Associated With Immune Activation in Women With HIV

(2021) Brandilyn A Peters et al.   JOURNAL OF INFECTIOUS DISEASES

DXA and clinical challenges of fracture risk assessment in primary care

(2021) Susan Williams et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Physical Functioning Among Patients Aging With Human Immunodeficiency Virus (HIV) Versus HIV Uninfected: Feasibility of Using the Short Physical Performance Battery in Clinical Care of People Living With HIV Aged 50 or Older

(2019) Heidi M Crane et al.   Open Forum Infectious Diseases

Grip Strength: An Indispensable Biomarker For Older Adults

(2019) Richard W Bohannon   Clinical Interventions in Aging

Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection

(2018) Mariska C. Vlot et al.   PLoS One

Frailty is an independent risk factor for mortality, cardiovascular disease, bone disease and diabetes among aging adults with HIV

(2018) Sean G Kelly et al.   CLINICAL INFECTIOUS DISEASES

Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection

(2016) Ighovwerha Ofotokun et al.   AIDS

Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment

(2016) Anton Pozniak et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Bone metabolism dysfunction mediated by the increase of proinflammatory cytokines in chronic HIV infection

(2016) Erika Grasiela Marques de Menezes et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Long-term Bone Mineral Density Changes in Antiretroviral-Treated HIV-Infected Individuals

(2016) Philip M. Grant et al.   JOURNAL OF INFECTIOUS DISEASES

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

(2016) Anthony Mills et al.   LANCET INFECTIOUS DISEASES

Which HIV patients should be screened for osteoporosis

(2016) Elena Alvarez et al.   Current Opinion in HIV and AIDS

Indicators of "Healthy Aging" in older women (65-69 years of age). A data-mining approach based on prediction of long-term survival

(2016) William R Swindell et al.   BMC Geriatrics

Recommendations for Evaluation and Management of Bone Disease in HIV

(2015) T. T. Brown et al.   CLINICAL INFECTIOUS DISEASES

Predictions of geriatric HIV in 2030

(2015) David E Vance et al.   LANCET INFECTIOUS DISEASES

Is bone loss linked to chronic inflammation in antiretroviral-naive HIV-infected adults? A 48-week matched cohort study

(2014) Corrilynn O. Hileman et al.   AIDS

Incident fractures in HIV-infected individuals

(2013) Stephanie Shiau et al.   AIDS

Soluble biomarkers of HIV transmission, disease progression and comorbidities

(2012) Edwin Leeansyah et al.   Current Opinion in HIV and AIDS

Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population

(2011) G. Guaraldi et al.   CLINICAL INFECTIOUS DISEASES

Fracture incidence in HIV-infected women: results from the Womenʼs Interagency HIV Study

(2010) Michael T Yin et al.   AIDS

Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study

(2010) Hans‐Jürgen Stellbrink et al.   CLINICAL INFECTIOUS DISEASES

Perspectives: How many women have osteoporosis now?

(2010) Joseph L. Melton   JOURNAL OF BONE AND MINERAL RESEARCH

The diagnosis of osteoporosis

(2010) John A. Kanis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Primary Care Use of FRAX®: Absolute Fracture Risk Assessment in Postmenopausal Women and Older Men

(2010) Ethel S. Siris et al.   POSTGRADUATE MEDICINE

Tenofovir-associated renal and bone toxicity

(2009) CLN Woodward et al.   HIV MEDICINE

Low Bone Mineral Density, Renal Dysfunction, and Fracture Risk in HIV Infection: A Cross‐Sectional Study

(2009) Alexandra Calmy et al.   JOURNAL OF INFECTIOUS DISEASES